← Browse by Condition
Medical Condition

oncology

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for oncology sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — oncology Clinical Trials

How many clinical trials are currently recruiting for oncology?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for oncology, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for oncology?
oncology research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a oncology clinical trial?
Eligibility criteria for oncology trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Institut Curie 1 trial
Centro di Riferimento Oncologico - Aviano 1 trial
Erasmus Medical Center 1 trial
UMC Utrecht 1 trial
Royal Marsden NHS Foundation Trust 1 trial

Recruiting Clinical Trials

NCT05781295
Recruiting
Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology
Enrollment
148 pts
Location
France
Sponsor
Institut Curie
View Trial →
NCT06668818
Recruiting
Clinical Nursing Practice Supported by Results of Research: Mixed-method Study
Enrollment
205 pts
Location
Italy
Sponsor
Centro di Riferimento Oncologi...
View Trial →
NCT06558487
Recruiting
The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
Enrollment
200 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
View Trial →
NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Location
United States, Austr...
Sponsor
UMC Utrecht
View Trial →
NCT05331066
Recruiting
Understanding immunE-related toXicities by multifACeT Profiling
Enrollment
200 pts
Location
United Kingdom
Sponsor
Royal Marsden NHS Foundation T...
View Trial →
NCT05320588 Phase 1, Phase 2
Recruiting
A Study in Patients With Advanced Cancers
Enrollment
332 pts
Location
United States
Sponsor
BiOneCure Therapeutics Inc.
View Trial →
NCT06531681
Recruiting
Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
Enrollment
3,000 pts
Location
China
Sponsor
The Second Affiliated Hospital...
View Trial →
NCT07341464
Recruiting
Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends
Enrollment
50 pts
Location
United Kingdom
Sponsor
Société des Produits Nestlé (S...
View Trial →

Related Conditions

radiation toxicity (2) quality of life (2) children (1) medical device (1) primary prevention (1) breast cancer (1) prostate cancer (1) gynecologic cancer (1) brain tumor (1) brain cancer (1) gynecologic tumor (1) prostate tumor (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology